Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).
BMJ Open
; 7(8): e015434, 2017 08 11.
Article
in En
| MEDLINE
| ID: mdl-28801400
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Proteostasis Deficiencies
/
Adrenergic alpha-2 Receptor Agonists
/
Endoplasmic Reticulum Stress
/
Guanabenz
/
Amyotrophic Lateral Sclerosis
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
BMJ Open
Year:
2017
Type:
Article
Affiliation country:
Italy